ERBB2 and breast carcinoma: Similar to the results with PancTu-I cells, we observed that γδ T cell cytotoxicity against other HER2-expressing tumor cells such as established breast cancer cell line MCF-7 (Figure 7B) or autologous primary OC cells OC11 (Figure 7C) was increased.